Back to Search
ROY FLEISCHMANN, M.D.
M.D.
Specialist
NPI: 1467451146Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Safety of biologic therapy in rheumatoid arthritis and other autoimmune diseases: focus on rituximab.
PMID 18336874·Semin Arthritis Rheum·2009
6-review
Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study.
PMID 19015206·Ann Rheum Dis·2009
4-observational
Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: a randomised controlled trial in patients with osteoarthritis.
PMID 18328090·BMC Musculoskelet Disord·2008
4-observational
Risk: benefit profile of etanercept in elderly patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis.
PMID 17362051·Drugs Aging·2007
6-review
Primer: establishing a clinical trial unit--obtaining studies and patients.
PMID 17664953·Nat Clin Pract Rheumatol·2007
6-review
Primer: establishing a clinical trial unit - regulations and infrastructure.
PMID 17396109·Nat Clin Pract Rheumatol·2007
6-review
Long term safety of etanercept in elderly subjects with rheumatic diseases.
PMID 16150792·Ann Rheum Dis·2006
1-meta
Comparison of the efficacy of biologic therapy for rheumatoid arthritis: can the clinical trials be accurately compared?
PMID 17410698·Rheum Dis Clin North Am·2006
4-observational
Safety of extended treatment with anakinra in patients with rheumatoid arthritis.
PMID 16396977·Ann Rheum Dis·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8144 WALNUT HILL LN, SUITE 800
DALLAS, TX 75231 - Phone
- (214) 540-0700
Quick Facts
- NPI
- 1467451146
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile